These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30381441)

  • 1. Nicotine-
    Perez-Paramo YX; Chen G; Ashmore JH; Watson CJW; Nasrin S; Adams-Haduch J; Wang R; Gao YT; Koh WP; Yuan JM; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):311-320. PubMed ID: 30381441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.
    Bloom AJ; Murphy SE; Martinez M; von Weymarn LB; Bierut LJ; Goate A
    Pharmacogenet Genomics; 2013 Feb; 23(2):62-8. PubMed ID: 23211429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain.
    Teitelbaum AM; Murphy SE; Akk G; Baker TB; Germann A; von Weymarn LB; Bierut LJ; Goate A; Kharasch ED; Bloom AJ
    Pharmacogenomics J; 2018 Jan; 18(1):136-143. PubMed ID: 28290528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.
    Störmer E; Roots I; Brockmöller J
    Br J Clin Pharmacol; 2000 Dec; 50(6):553-61. PubMed ID: 11136294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro-in vivo correlations of human (S)-nicotine metabolism.
    Berkman CE; Park SB; Wrighton SA; Cashman JR
    Biochem Pharmacol; 1995 Aug; 50(4):565-70. PubMed ID: 7646564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of nicotine in rat lung microvascular endothelial cells.
    Ochiai Y; Sakurai E; Nomura A; Itoh K; Tanaka Y
    J Pharm Pharmacol; 2006 Mar; 58(3):403-7. PubMed ID: 16536909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour.
    Tricker AR
    Toxicology; 2003 Feb; 183(1-3):151-73. PubMed ID: 12504349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms.
    Siddens LK; Henderson MC; Vandyke JE; Williams DE; Krueger SK
    Biochem Pharmacol; 2008 Jan; 75(2):570-9. PubMed ID: 17942081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.
    Chenoweth MJ; Zhu AZ; Sanderson Cox L; Ahluwalia JS; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2014 Mar; 24(3):172-6. PubMed ID: 24448396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes.
    Murphy SE; Raulinaitis V; Brown KM
    Drug Metab Dispos; 2005 Aug; 33(8):1166-73. PubMed ID: 15860657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.
    Murphy SE
    Chem Res Toxicol; 2017 Jan; 30(1):410-419. PubMed ID: 28092945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.
    Perez-Paramo YX; Watson CJW; Chen G; Thomas CE; Adams-Haduch J; Wang R; Khor CC; Koh WP; Nelson HH; Yuan JM; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):54-65. PubMed ID: 36252563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1'-oxide.
    Park SB; Jacob P; Benowitz NL; Cashman JR
    Chem Res Toxicol; 1993; 6(6):880-8. PubMed ID: 8117928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C-Oxidation and Coumarin 7-Hydroxylation Activities.
    Hosono H; Kumondai M; Maekawa M; Yamaguchi H; Mano N; Oda A; Hirasawa N; Hiratsuka M
    Drug Metab Dispos; 2017 Mar; 45(3):279-285. PubMed ID: 27974382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms.
    Lang DH; Rettie AE
    Br J Clin Pharmacol; 2000 Oct; 50(4):311-4. PubMed ID: 11012553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and sequencing of flavin-containing monooxygenases FMO3 and FMO4 from rabbit and characterization of FMO3.
    Burnett VL; Lawton MP; Philpot RM
    J Biol Chem; 1994 May; 269(19):14314-22. PubMed ID: 8188717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide.
    Cashman JR; Park SB; Yang ZC; Wrighton SA; Jacob P; Benowitz NL
    Chem Res Toxicol; 1992; 5(5):639-46. PubMed ID: 1446003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of Ten Urinary Nicotine Metabolites, Including 4-Hydroxy-4-(3-pyridyl) Butanoic Acid, a Product of Nicotine 2'-Oxidation, and CYP2A6 Activity in Japanese Americans, Native Hawaiians, and Whites.
    von Weymarn LB; Lu X; Thomson NM; LeMarchand L; Park SL; Murphy SE
    Chem Res Toxicol; 2023 Feb; 36(2):313-321. PubMed ID: 36735658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of enzymes responsible for the N-oxidation of darexaban glucuronide, the pharmacologically active metabolite of darexaban, and the glucuronidation of darexaban N-oxides in human liver microsomes.
    Shiraga T; Yajima K; Teragaki T; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Biol Pharm Bull; 2012; 35(3):413-21. PubMed ID: 22382330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.